Remove tag 2023-trends
article thumbnail

Walmart Introduces bettergoods, a New Private Label Brand

XTalks

The Launch of bettergoods bettergoods represents Walmart’s largest and quickest food brand launch, showcasing the company’s ability to rapidly respond to market trends. According to a recent Circana report from March, private label brand sales in the US saw a six percent year-over-year increase, totaling $217 billion in 2023.

article thumbnail

Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Fleurence, PhD, MSc; Joshua M. Sharfstein, MD)

Rethinking Clinical Trials

The current trends of Hepatitis C epidemiology in the U.S. Tags #pctGR, @Collaboratory1 The post Grand Rounds October 20, 2023: A National Initiative to Eliminate Hepatitis C in the United States – Why This Matters to Clinical Trialists (Rachael L. Discussions are currently underway with 13 partner sites.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Conjugation and Labeling of Molecules: A Burgeoning Approach in Therapeutics Development and Molecular Imaging

Roots Analysis

These molecules can be conjugated with various modalities, such as haptens, enzymes, isotopes, fluorescent tags, carrier proteins, polymers, particle conjugates and photoreactive molecules. Bioconjugation is a subset of conjugation where one of the entity is a biomolecule, such as protein or an antibody.

article thumbnail

Unveiling Potential: Exploring Alpha Emitter Radiopharmaceuticals

XTalks

In 2023, there have been pivotal trends shaping the landscape and application of alpha emitter therapy. This biological variability adds complexity, but with that complexity comes the power to choose the targets, the tags and the payloads and select combinations appropriate to the patient to personalize that therapy.

DNA 66
article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

The companies have also entered into an agreement with Canada to supply up to 125 million doses in 2022 and 2023, with options to purchase up to 60 million additional doses in 2024. Therefore, Pfizer’s first quarter for U.S. reflects the three months ended on February 28, 2021 and February 23, 2020. (6) Amy Rose 212.733.7410. Source link.